Anavex Life Sciences (AVXL) Short Interest Ratio & Short Volume $8.73 -0.13 (-1.47%) As of 12:01 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Anavex Life Sciences Short Interest DataAnavex Life Sciences (AVXL) has a short interest of 24.59 million shares, representing 32.48% of the float (the number of shares available for trading by the public). This marks a 2.29% increase in short interest from the previous month. The short interest ratio (days to cover) is 18.8, indicating that it would take 18.8 days of the average trading volume of 1.26 million shares to cover all short positions.Current Short Interest24,590,000 sharesPrevious Short Interest24,040,000 sharesChange Vs. Previous Month+2.29%Dollar Volume Sold Short$210.98 millionShort Interest Ratio18.8 Days to CoverLast Record DateMarch 31, 2025Outstanding Shares85,064,000 sharesShort Percent of Float32.48%Today's Trading Volume188,820 sharesAverage Trading Volume1,260,065 sharesToday's Volume Vs. Average15% Short Selling Anavex Life Sciences? Sign up to receive the latest short interest report for Anavex Life Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAVXL Short Interest Over TimeAVXL Days to Cover Over TimeAVXL Percentage of Float Shorted Over Time Remove Ads Anavex Life Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202524,590,000 shares $210.98 million +2.3%32.5%18.8 $8.58 3/15/202524,040,000 shares $226.70 million +2.6%31.8%14.9 $9.43 2/28/202523,440,000 shares $185.41 million -3.1%31.0%14.2 $7.91 2/15/202524,200,000 shares $206.18 million +3.3%32.0%14.2 $8.52 1/31/202523,430,000 shares $217.20 million +0.1%N/A12.9 $9.27 1/15/202523,400,000 shares $265.12 million +7.3%N/A12.3 $11.33 12/31/202421,800,000 shares $234.13 million +4.7%N/A12.7 $10.74 12/15/202420,820,000 shares $176.14 million +5.7%N/A15.8 $8.46 11/30/202419,690,000 shares $186.27 million +4.7%N/A17.3 $9.46 11/15/202418,810,000 shares $140.04 million +2.7%N/A18.1 $7.45 Get the Latest News and Ratings for AVXL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Anavex Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 10/31/202418,310,000 shares $121.21 million +2.2%N/A21.1 $6.62 10/15/202417,910,000 shares $96.53 million +1.8%N/A22.7 $5.39 9/30/202417,590,000 shares $99.91 million -10.3%N/A19.5 $5.68 9/15/202419,610,000 shares $104.13 million +1.1%N/A20.1 $5.31 8/31/202419,390,000 shares $116.73 million -1.8%N/A17.8 $6.02 8/15/202419,750,000 shares $124.62 million -0.7%N/A17.2 $6.31 7/31/202419,880,000 shares $135.08 million +7.8%N/A16.3 $6.80 7/15/202418,440,000 shares $107.51 million +3.4%N/A15.8 $5.83 6/30/202417,830,000 shares $75.24 million -14.9%N/A15.4 $4.22 6/15/202420,940,000 shares $78.94 million -4.0%N/A17.6 $3.77 5/31/202421,820,000 shares $88.59 million -0.2%N/A17.6 $4.06 5/15/202421,860,000 shares $98.15 million +2.7%N/A17.5 $4.49 4/30/202421,290,000 shares $77.71 million -3.3%N/A16.6 $3.65 4/15/202422,010,000 shares $93.10 million -0.5%N/A17.1 $4.23 3/31/202422,120,000 shares $112.59 million +10.6%N/A17.3 $5.09 3/15/202420,000,000 shares $102.20 million -0.1%N/A13.4 $5.11 2/29/202420,020,000 shares $102.90 million +0.7%N/A13.9 $5.14 2/15/202419,890,000 shares $115.96 million -1.2%N/A13.7 $5.83 1/31/202420,130,000 shares $120.18 million -2.6%N/A13.9 $5.97 1/15/202420,660,000 shares $123.75 million +2.9%N/A14.4 $5.99 12/31/202320,070,000 shares $186.85 million +10.8%N/A14.8 $9.31 12/15/202318,120,000 shares $160.18 million +0.8%N/A16.6 $8.84 11/30/202317,970,000 shares $129.56 million -0.8%N/A17.6 $7.21 11/15/202318,120,000 shares $111.98 million -2.6%N/A18.8 $6.18 10/31/202318,610,000 shares $103.84 million +4.5%N/A20.3 $5.58 10/15/202317,810,000 shares $107.75 million -0.9%N/A20.5 $6.05 9/30/202317,970,000 shares $117.70 million +5.2%N/A21.8 $6.55 9/15/202317,090,000 shares $129.37 million +1.2%N/A20.4 $7.57 8/31/202316,880,000 shares $133.35 million +1.0%N/A19.3 $7.90 8/15/202316,720,000 shares $149.48 million +1.1%N/A18.5 $8.94Feds Just Admitted It—They Can Take Your Cash (Ad)Here’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousands of smart, forward-thinking individuals are making the move—out of the system and into real, untouchable assets. Because once your funds are frozen, it’s too late.👉 Click here to find out how to protect every dollar you’ve earned—before it disappears behind red 7/31/202316,540,000 shares $136.46 million -1.1%N/A18.1 $8.25 7/15/202316,730,000 shares $140.87 million -0.1%N/A18.8 $8.42 6/30/202316,740,000 shares $136.10 million -5.6%N/A17.8 $8.13 6/15/202317,740,000 shares $156.64 million +7.5%N/A17.9 $8.83 5/31/202316,510,000 shares $152.55 million +3.8%N/A15.9 $9.24 5/15/202315,900,000 shares $150.89 million +10.6%N/A15.9 $9.49 4/30/202314,380,000 shares $117.05 million -7.8%N/A13.7 $8.14 4/15/202315,590,000 shares $122.85 million -1.9%N/A14.4 $7.88 3/31/202315,890,000 shares $136.18 million +1.3%N/A13.8 $8.57 3/15/202315,680,000 shares $146.76 million -3.9%N/A13.2 $9.36 2/28/202316,320,000 shares $155.37 million -4.7%N/A7.5 $9.52 2/15/202317,130,000 shares $179.35 million +2.5%N/A7.4 $10.47 1/31/202316,720,000 shares $181.75 million -9.0%N/A7.1 $10.87 1/15/202318,370,000 shares $194.35 million +0.7%N/A8.1 $10.58 12/30/202218,250,000 shares $169.00 million +15.7%N/A8.2 $9.26 12/15/202215,780,000 shares $131.76 million +32.5%N/A7.3 $8.35 11/30/202211,910,000 shares $105.05 million +17.1%N/A6 $8.82 11/15/202210,170,000 shares $142.89 million +0.6%N/A11.6 $14.05 10/31/202210,110,000 shares $123.04 million +0.7%N/A12.7 $12.17 10/15/202210,040,000 shares $106.42 million -2.1%N/A12.5 $10.60 9/30/202210,260,000 shares $105.88 million +5.3%N/A13 $10.32 9/15/20229,740,000 shares $92.63 million +7.0%N/A12.1 $9.51 8/31/20229,100,000 shares $87.27 million +8.0%N/A10.6 $9.59 8/15/20228,430,000 shares $100.06 million -3.4%N/A9.6 $11.87 7/31/20228,730,000 shares $89.57 million +5.7%N/A9.3 $10.26 7/15/20228,260,000 shares $104.90 million -5.2%N/A8.8 $12.70 6/30/20228,710,000 shares $87.19 million -8.3%N/A9.7 $10.01 6/15/20229,500,000 shares $76.95 million +6.6%N/A10.6 $8.10 5/31/20228,910,000 shares $81.17 million +1.5%N/A10.1 $9.11 5/15/20228,780,000 shares $75.42 million +8.0%N/A9.4 $8.59 4/30/20228,130,000 shares $69.84 million +3.2%N/A8.5 $8.59 4/15/20227,880,000 shares $87.47 million +3.6%N/A6.9 $11.10 3/31/20227,610,000 shares $93.68 million -5.4%N/A6.3 $12.31 3/15/20228,040,000 shares $85.63 million +2.4%N/A6.6 $10.65 2/28/20227,850,000 shares $86.04 million No ChangeN/A6.6 $10.96 2/15/20227,850,000 shares $99.85 million +34.0%N/A6.4 $12.72 1/31/20225,860,000 shares $76.65 million +21.1%N/A5.1 $13.08 1/15/20224,840,000 shares $69.65 million +7.6%N/A5.2 $14.39 12/31/20214,500,000 shares $78.03 million -6.8%N/A5.3 $17.34 12/15/20214,830,000 shares $92.45 million +0.4%N/A5.8 $19.14 11/30/20214,810,000 shares $93.31 million +9.1%N/A5.9 $19.40 11/15/20214,410,000 shares $94.82 million -14.0%9.9%5.5 $21.50 10/29/20215,130,000 shares $96.14 million +0.4%11.5%6.1 $18.74 10/15/20215,110,000 shares $89.53 million -12.2%11.5%5.3 $17.52 9/30/20215,820,000 shares $104.47 million +3.4%13.1%4.8 $17.95 9/15/20215,630,000 shares $96.10 million -5.5%N/A3.2 $17.07 8/31/20215,960,000 shares $116.16 million -14.1%N/A2.3 $19.49 8/13/20216,940,000 shares $135.68 million +3.7%N/A2.6 $19.55 7/30/20216,690,000 shares $120.09 million -12.0%N/A2.5 $17.95 7/15/20217,600,000 shares $168.42 million -13.3%N/A3.1 $22.16Feds Just Admitted It—They Can Take Your Cash (Ad)Here’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousands of smart, forward-thinking individuals are making the move—out of the system and into real, untouchable assets. Because once your funds are frozen, it’s too late.👉 Click here to find out how to protect every dollar you’ve earned—before it disappears behind red 6/30/20218,770,000 shares $200.48 million +24.9%12.5%3.7 $22.86 6/15/20217,020,000 shares $121.73 million +7.3%10.4%3.8 $17.34 5/28/20216,540,000 shares $81.42 million -0.3%9.7%5.7 $12.45 5/14/20216,560,000 shares $66.65 million -4.9%N/A5 $10.16 4/30/20216,900,000 shares $84.53 million +8.0%N/A4.2 $12.25 4/15/20216,390,000 shares $82.24 million +13.9%N/A1.6 $12.87 3/31/20215,610,000 shares $78.71 million +55.8%N/A1.4 $14.03 3/15/20213,600,000 shares $50.51 million -9.1%N/A0.9 $14.03 2/26/20213,960,000 shares $51.72 million -1.3%N/A1 $13.06 2/12/20214,010,000 shares $50.95 million -23.8%N/A1.1 $12.71 1/29/20215,260,000 shares $33.35 million -5.7%N/A1.4 $6.34 1/15/20215,580,000 shares $33.03 million -0.7%N/A4.3 $5.92 12/31/20205,620,000 shares $30.85 million -16.4%N/A3.7 $5.49 12/15/20206,720,000 shares $34.88 million -9.6%N/A4.5 $5.19 11/30/20207,430,000 shares $39.90 million -3.9%N/A6 $5.37 11/15/20207,730,000 shares $41.59 million +17.3%N/A6.6 $5.38 10/30/20206,590,000 shares $39.41 million -6.9%N/A5.9 $5.98 10/15/20207,080,000 shares $30.73 million -3.7%N/A7.6 $4.34 9/30/20207,350,000 shares $33.44 million -4.2%N/A11.5 $4.55 9/15/20207,670,000 shares $30.83 million +6.5%N/A12 $4.02 8/31/20207,200,000 shares $30.53 million -3.4%N/A9.8 $4.24 8/14/20207,450,000 shares $31.22 million +23.1%N/A9.9 $4.19 7/31/20206,050,000 shares $25.53 million -12.3%N/A7.6 $4.22 7/15/20206,900,000 shares $31.33 million +8.0%N/A9.4 $4.54 6/30/20206,390,000 shares $31.44 million +5.1%N/A8.8 $4.92 6/15/20206,080,000 shares $24.81 million -6.0%N/A8.1 $4.08 5/29/20206,470,000 shares $26.59 million -11.5%N/A8.3 $4.11 5/15/20207,310,000 shares $25.59 million -0.1%N/A8.1 $3.50 4/30/20207,320,000 shares $25.33 million -2.4%N/A6.5 $3.46 4/15/20207,500,000 shares $23.78 million +4.0%N/A6.1 $3.17 AVXL Short Interest - Frequently Asked Questions What is Anavex Life Sciences' current short interest? Short interest is the volume of Anavex Life Sciences shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 24,590,000 shares of AVXL short. 32.48% of Anavex Life Sciences' shares are currently sold short. Learn More on Anavex Life Sciences' current short interest. What is a good short interest ratio for Anavex Life Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AVXL shares currently have a short interest ratio of 19.0. Learn More on Anavex Life Sciences's short interest ratio. Which institutional investors are shorting Anavex Life Sciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Anavex Life Sciences: Wolverine Trading LLC, Sculptor Capital LP, LMR Partners LLP, Group One Trading LLC, Citadel Advisors LLC, Susquehanna International Group LLP, Concourse Financial Group Securities Inc., Walleye Trading LLC, Walleye Capital LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Anavex Life Sciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 32.48% of Anavex Life Sciences' floating shares are currently sold short. Is Anavex Life Sciences' short interest increasing or decreasing? Anavex Life Sciences saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 24,590,000 shares, an increase of 2.3% from the previous total of 24,040,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Anavex Life Sciences' short interest compare to its competitors? 32.48% of Anavex Life Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Anavex Life Sciences: SpringWorks Therapeutics, Inc. (10.96%), Protagonist Therapeutics, Inc. (9.10%), Catalyst Pharmaceuticals, Inc. (7.47%), Merus (12.34%), Alvotech (0.59%), Apellis Pharmaceuticals, Inc. (19.42%), Scholar Rock Holding Co. (21.32%), Crinetics Pharmaceuticals, Inc. (9.80%), Immunovant, Inc. (22.78%), ACADIA Pharmaceuticals Inc. (13.09%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Capital One Financial Co. ($3.79 billion), AppLovin Co. ($2.91 billion), Corcept Therapeutics Incorporated ($1.89 billion), Amcor plc ($1.60 billion), Carnival Co. & plc ($1.16 billion), BCE Inc. ($1.14 billion), AST SpaceMobile, Inc. ($1.10 billion), and Best Buy Co., Inc. ($1.03 billion). View all of the most shorted stocks. What does it mean to sell short Anavex Life Sciences stock? Short selling AVXL is an investing strategy that aims to generate trading profit from Anavex Life Sciences as its price is falling. AVXL shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Anavex Life Sciences? A short squeeze for Anavex Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AVXL, which in turn drives the price of the stock up even further. How often is Anavex Life Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AVXL, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies SWTX Short Interest Data PTGX Short Interest Data CPRX Short Interest Data MRUS Short Interest Data ALVO Short Interest Data APLS Short Interest Data SRRK Short Interest Data CRNX Short Interest Data IMVT Short Interest Data ACAD Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AVXL) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredThe biggest story CNBC isn't talking about (yet)This Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredTrump’s betrayal exposed Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredVolatility's Next Big Opportunity?With tariffs rattling the markets, many investors are watching helplessly… But according to legendary "Mark...Brownstone Research | SponsoredTrump 2028 could be a “bonanza” for investorsAs you may have heard, Donald Trump is planning to run for a THIRD term in 2028. Recently he told NBC news ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anavex Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anavex Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AVXL Stock Free AVXL Stock Alerts